Ibrahim Edhemovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ibrahim Edhemovic has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Gregor Sersa
Institute of Oncology Ljubljana
3 shared publications - Maja Cemazar
Institute of Oncology Ljubljana
3 shared publications - Andrés Cervantes
INCLIVA Biomedical Research Institute, 46010 Valencia, Spain
2 shared publications - Annet G H Roodvoets
Clinical Research Center, Department of Surgery Leiden University Medical Center Leiden the Netherlands
2 shared publications - Bor Kos
Faculty of Electrical Engineering, University of Ljubljana, Ljubljana, Slovenia
2 shared publications - Cristina Dopazo
Department of HPB Surgery and Liver Transplant, Department of Surgery Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona Barcelona Spain
2 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 65, 818-835
Tools for providing information to patients about high-tech medical resources for treatment of cancer
Background and purpose: High-tech medical resources play an increasingly important role in cancer diagnosis and treatment. However, accessing information about these technologies remains challenging due to their complexity and a lack of clear information pathways to obtain reliable information. This, in turn, contributes to inequalities in healthcare. Patient/material and methods: The Joint Action Network of Expertise on Cancer (JANE-2) is one of the largest networks under Europe’s Beating Cancer Plan. In JANE-2, the work package on High-Tech Medical Resources comprises seven domains of rapidly evolving technologies, namely Nuclear Medicine, Radiomics, Innovative Radiotherapy, Innovative Surgery, Physical Methods of Ablation, Cell Therapies, and Ex-vivo Testing of Agents. Leaders from these domains, together with patient representatives, have authored a review of the challenges of providing patients with information about high-tech medical resources, and have proposed potential solutions. Results: This article describes the challenges associated with providing adequate information to patients, the resulting consequences, and potential solutions. The article also specifically describes technologies related to the seven high-tech domains that are central to cancer treatment. Patient information tools related to these technologies are provided as supplementary material to the article. Interpretation: Cancer diagnosis and treatment are not only becoming increasingly effective but also more complex with the adoption of novel technologies. This article discusses the challenges and potential solutions related to the availability of patient information and provides examples of patient information tools for seven key and rapidly advancing technologies.
- 2 October 2026
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 65, 818-835
Open AccessTools for providing information to patients about high-tech medical resources for treatment of cancer
Background and purpose: High-tech medical resources play an increasingly important role in cancer diagnosis and treatment. However, accessing information about these technologies remains challenging due to their complexity and a lack of clear information pathways to obtain reliable information. This, in turn, contributes to inequalities in healthcare. Patient/material and methods: The Joint Action Network of Expertise on Cancer (JANE-2) is one of the largest networks under Europe’s Beating Cancer Plan. In JANE-2, the work package on High-Tech Medical Resources comprises seven domains of rapidly evolving technologies, namely Nuclear Medicine, Radiomics, Innovative Radiotherapy, Innovative Surgery, Physical Methods of Ablation, Cell Therapies, and Ex-vivo Testing of Agents. Leaders from these domains, together with patient representatives, have authored a review of the challenges of providing patients with information about high-tech medical resources, and have proposed potential solutions. Results: This article describes the challenges associated with providing adequate information to patients, the resulting consequences, and potential solutions. The article also specifically describes technologies related to the seven high-tech domains that are central to cancer treatment. Patient information tools related to these technologies are provided as supplementary material to the article. Interpretation: Cancer diagnosis and treatment are not only becoming increasingly effective but also more complex with the adoption of novel technologies. This article discusses the challenges and potential solutions related to the availability of patient information and provides examples of patient information tools for seven key and rapidly advancing technologies.
- Open Access
- 25 February 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (6) , 109728
Liver metastases from colorectal cancer: A joint ESSO–EAHPBA–UEMS core curriculum collaboration
- 25 February 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (6) , 109728
Open AccessLiver metastases from colorectal cancer: A joint ESSO–EAHPBA–UEMS core curriculum collaboration
- Top Cited PapersOpen Access
- 20 January 2023
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 278 (4) , e766-e772
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery
Objective: To analyze risk and patterns of locoregional failure (LRF) in patients of the RAPIDO trial at 5 years. Background: Multimodality treatment improves local control in rectal cancer. Total neoadjuvant treatment (TNT) aims to improve systemic control while local control is maintained. At 3 years, LRF rate was comparable between TNT and chemoradiotherapy in the RAPIDO trial. Methods: A total of 920 patients were randomized between an experimental (EXP, short-course radiotherapy, chemotherapy, and surgery) and a standard-care group (STD, chemoradiotherapy, surgery, and optional postoperative chemotherapy). LRFs, including early LRF (no resection except for organ preservation/R2 resection) and locoregional recurrence (LRR) after an R0/R1 resection, were analyzed. Results: Totally, 460 EXP and 446 STD patients were eligible. At 5.6 years (median follow-up), LRF was detected in 54/460 (12%) and 36/446 (8%) patients in the EXP and STD groups, respectively (P=0.07), in which EXP patients were more often treated with 3-dimensional-conformed radiotherapy (P=0.029). In the EXP group, LRR was detected more often [44/431 (10%) vs. 26/428 (6%); P=0.027], with more often a breached mesorectum (9/44 (21%) vs. 1/26 (4); P=0.048). The EXP treatment, enlarged lateral lymph nodes, positive circumferential resection margin, tumor deposits, and node positivity at pathology were the significant predictors for developing LRR. Location of the LRRs was similar between groups. Overall survival after LRF was comparable [hazard ratio: 0.76 (95% CI, 0.46–1.26); P=0.29]. Conclusions: The EXP treatment was associated with an increased risk of LRR, whereas the reduction in disease-related treatment failure and distant metastases remained after 5 years. Further refinement of the TNT in rectal cancer is mandated.
- 20 January 2023
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 278 (4) , e766-e772
Top Cited PapersOpen AccessLocoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery
Objective: To analyze risk and patterns of locoregional failure (LRF) in patients of the RAPIDO trial at 5 years. Background: Multimodality treatment improves local control in rectal cancer. Total neoadjuvant treatment (TNT) aims to improve systemic control while local control is maintained. At 3 years, LRF rate was comparable between TNT and chemoradiotherapy in the RAPIDO trial. Methods: A total of 920 patients were randomized between an experimental (EXP, short-course radiotherapy, chemotherapy, and surgery) and a standard-care group (STD, chemoradiotherapy, surgery, and optional postoperative chemotherapy). LRFs, including early LRF (no resection except for organ preservation/R2 resection) and locoregional recurrence (LRR) after an R0/R1 resection, were analyzed. Results: Totally, 460 EXP and 446 STD patients were eligible. At 5.6 years (median follow-up), LRF was detected in 54/460 (12%) and 36/446 (8%) patients in the EXP and STD groups, respectively (P=0.07), in which EXP patients were more often treated with 3-dimensional-conformed radiotherapy (P=0.029). In the EXP group, LRR was detected more often [44/431 (10%) vs. 26/428 (6%); P=0.027], with more often a breached mesorectum (9/44 (21%) vs. 1/26 (4); P=0.048). The EXP treatment, enlarged lateral lymph nodes, positive circumferential resection margin, tumor deposits, and node positivity at pathology were the significant predictors for developing LRR. Location of the LRRs was similar between groups. Overall survival after LRF was comparable [hazard ratio: 0.76 (95% CI, 0.46–1.26); P=0.29]. Conclusions: The EXP treatment was associated with an increased risk of LRR, whereas the reduction in disease-related treatment failure and distant metastases remained after 5 years. Further refinement of the TNT in rectal cancer is mandated.
- Open Access
- 20 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Numerical mesoscale tissue model of electrochemotherapy in liver based on histological findings
Electrochemotherapy (ECT) and irreversible electroporation (IRE) are being investigated for treatment of hepatic tumours. The liver is a highly heterogeneous organ, permeated with a network of macro- and microvasculature, biliary tracts and connective tissue. The success of ECT and IRE depends on sufficient electric field established in whole target tissue; therefore, tissue heterogeneity may affect the treatment outcome. In this study, we investigate electroporation in the liver using a numerical mesoscale tissue model. We numerically reconstructed four ECT experiments in healthy porcine liver and computed the electric field distribution using our treatment planning framework. We compared the computed results with histopathological changes identified on microscopic images after treatment. The mean electric field threshold that best fitted the zone of coagulation necrosis was 1225 V/cm, while the mean threshold that best fitted the zone of partially damaged liver parenchyma attributed to IRE was 805 V/cm. We evaluated how the liver macro- and microstructures affect the electric field distribution. Our results show that the liver microstructure does not significantly affect the electric field distribution on the level needed for treatment planning. However, major hepatic vessels and portal spaces significantly affect the electric field distribution, and should be considered when planning treatments.
- 20 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessNumerical mesoscale tissue model of electrochemotherapy in liver based on histological findings
Electrochemotherapy (ECT) and irreversible electroporation (IRE) are being investigated for treatment of hepatic tumours. The liver is a highly heterogeneous organ, permeated with a network of macro- and microvasculature, biliary tracts and connective tissue. The success of ECT and IRE depends on sufficient electric field established in whole target tissue; therefore, tissue heterogeneity may affect the treatment outcome. In this study, we investigate electroporation in the liver using a numerical mesoscale tissue model. We numerically reconstructed four ECT experiments in healthy porcine liver and computed the electric field distribution using our treatment planning framework. We compared the computed results with histopathological changes identified on microscopic images after treatment. The mean electric field threshold that best fitted the zone of coagulation necrosis was 1225 V/cm, while the mean threshold that best fitted the zone of partially damaged liver parenchyma attributed to IRE was 805 V/cm. We evaluated how the liver macro- and microstructures affect the electric field distribution. Our results show that the liver microstructure does not significantly affect the electric field distribution on the level needed for treatment planning. However, major hepatic vessels and portal spaces significantly affect the electric field distribution, and should be considered when planning treatments.
- Open Access
- 1 November 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (11) , e1-e30
The ESSO core curriculum committee update on surgical oncology
- 1 November 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (11) , e1-e30
Open AccessThe ESSO core curriculum committee update on surgical oncology
- Open Access
- 1 September 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (9) , 1628-1633
Intraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II study
- 1 September 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (9) , 1628-1633
Open AccessIntraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II study
- Top Cited Papers
- 1 June 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 147, 75-83
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
- 1 June 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 147, 75-83
Top Cited PapersCompliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
- Open Access
- 27 August 2015
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 14 (S3) , S5
Electrochemotherapy of colorectal liver metastases - an observational study of its effects on the electrocardiogram
Electrochemotherapy (ECT) is a combined treatment in which high voltage electroporation (EP) pulses are used to facilitate the uptake of a chemotherapeutic drug into tumor cells, thus increasing antitumor effectiveness of the drug. The effect of ECT of deep-seated tumors located close to the heart on functioning of the heart has not been previously investigated. In this study, we investigate the effects of intra-abdominal ECT of colorectal liver metastases on functioning of the heart during the early post-operative care period. For ECT high voltage EP pulses with amplitudes of up to 3000 V and 30 A were delivered in synchronization with electrical activity of the heart. Holter electrocardiographic (ECG) signals were obtained from 10 patients with colorectal liver metastases treated with ECT. ECG was recorded during the periods of 24 hours before and after the surgical procedure involving ECT. Four-hour long night-time ECG segments from both periods exhibiting the highest level of signal stationarity were analyzed and compared. Changes in several ECG and heart rate variability (HRV) parameters were evaluated. No major heart rhythm changes (i.e., induction of extrasystoles, ventricular tachycardia or fibrillation) or pathological morphological changes (i.e., ST segment changes) indicating myocardial ischemia were found. However, we found several minor statistically significant but clinically irrelevant changes in HRV parameters after ECT procedures: a decrease in median values of the mean NN interval, a decrease in the low-frequency and in the normalized low-frequency component, and an increase in the normalized high-frequency component. Only minor effects of intra-abdominal ECT treatment on functioning of the heart were found. They were expressed as statistically significant but clinically irrelevant changes in heart rate and long-term HRV parameters and were as such not life-threatening to the patients. The nature of these changes is such that they can be attributed to the known effects of the drugs given to the patients in the post-operative care. Further investigation is still warranted to unambiguously resolve whether ECT with high voltage EP pulses applied in immediate vicinity of the heart is responsible for the observed effects.
- 27 August 2015
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 14 (S3) , S5
Open AccessElectrochemotherapy of colorectal liver metastases - an observational study of its effects on the electrocardiogram
Electrochemotherapy (ECT) is a combined treatment in which high voltage electroporation (EP) pulses are used to facilitate the uptake of a chemotherapeutic drug into tumor cells, thus increasing antitumor effectiveness of the drug. The effect of ECT of deep-seated tumors located close to the heart on functioning of the heart has not been previously investigated. In this study, we investigate the effects of intra-abdominal ECT of colorectal liver metastases on functioning of the heart during the early post-operative care period. For ECT high voltage EP pulses with amplitudes of up to 3000 V and 30 A were delivered in synchronization with electrical activity of the heart. Holter electrocardiographic (ECG) signals were obtained from 10 patients with colorectal liver metastases treated with ECT. ECG was recorded during the periods of 24 hours before and after the surgical procedure involving ECT. Four-hour long night-time ECG segments from both periods exhibiting the highest level of signal stationarity were analyzed and compared. Changes in several ECG and heart rate variability (HRV) parameters were evaluated. No major heart rhythm changes (i.e., induction of extrasystoles, ventricular tachycardia or fibrillation) or pathological morphological changes (i.e., ST segment changes) indicating myocardial ischemia were found. However, we found several minor statistically significant but clinically irrelevant changes in HRV parameters after ECT procedures: a decrease in median values of the mean NN interval, a decrease in the low-frequency and in the normalized low-frequency component, and an increase in the normalized high-frequency component. Only minor effects of intra-abdominal ECT treatment on functioning of the heart were found. They were expressed as statistically significant but clinically irrelevant changes in heart rate and long-term HRV parameters and were as such not life-threatening to the patients. The nature of these changes is such that they can be attributed to the known effects of the drugs given to the patients in the post-operative care. Further investigation is still warranted to unambiguously resolve whether ECT with high voltage EP pulses applied in immediate vicinity of the heart is responsible for the observed effects.
- 1 October 2004
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (10) , 941-947
The Computer Synoptic Operative Report—A Leap Forward in the Science of Surgery
Background: Quality of surgery is a proven prognostic factor in many tumors. It is critical to ensure that an effective method is in place to evaluate surgery accurately. Material and Methods: A provincial Cancer Surgery Working Group designed and piloted a computerized synoptic operative report template (WebSMR) in rectal cancer surgery, to replace the standard narrative operative record (NR). This included a precise description of the procedure, data on demographics, diagnostic evaluation, staging, and functional measures. A total of 70 items for anterior resection (AR) and 63 items for abdominoperinal excision (APR) were included. The WebSMR was assessed for comparison with 40 NR randomly selected from seven hospitals in Southern Alberta from 2001 to 2003. Results: The NR contained 45.9% of the specified data elements and the WebSMR captured 99%. The most complete NR data (68.8% to 97%) concerned hospital and patient data, anesthetist and surgeon information, approach, and closure details. The important details of laparotomy and tumor resection were the next most complete data (33.5% to 47.5%) and the least complete (0 to 25%) concerned preoperative treatment, comorbidity, and metastatic and local assessment. All differences among these groups were statistically different (P < .001). No statistically significant differences were seen in the completeness of the NR according to the type of surgery (AR vs. APR; P = .1) or the dictating surgeon (colorectal vs. general vs. resident; P = .175). The time needed to complete the WebSMR test was only 6 minutes. Conclusion: The science of surgical technique can be better measured by this unique instrument and will create accountability in surgery.
- 1 October 2004
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (10) , 941-947
The Computer Synoptic Operative Report—A Leap Forward in the Science of Surgery
Background: Quality of surgery is a proven prognostic factor in many tumors. It is critical to ensure that an effective method is in place to evaluate surgery accurately. Material and Methods: A provincial Cancer Surgery Working Group designed and piloted a computerized synoptic operative report template (WebSMR) in rectal cancer surgery, to replace the standard narrative operative record (NR). This included a precise description of the procedure, data on demographics, diagnostic evaluation, staging, and functional measures. A total of 70 items for anterior resection (AR) and 63 items for abdominoperinal excision (APR) were included. The WebSMR was assessed for comparison with 40 NR randomly selected from seven hospitals in Southern Alberta from 2001 to 2003. Results: The NR contained 45.9% of the specified data elements and the WebSMR captured 99%. The most complete NR data (68.8% to 97%) concerned hospital and patient data, anesthetist and surgeon information, approach, and closure details. The important details of laparotomy and tumor resection were the next most complete data (33.5% to 47.5%) and the least complete (0 to 25%) concerned preoperative treatment, comorbidity, and metastatic and local assessment. All differences among these groups were statistically different (P < .001). No statistically significant differences were seen in the completeness of the NR according to the type of surgery (AR vs. APR; P = .1) or the dictating surgeon (colorectal vs. general vs. resident; P = .175). The time needed to complete the WebSMR test was only 6 minutes. Conclusion: The science of surgical technique can be better measured by this unique instrument and will create accountability in surgery.
- 1 September 2001
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (6) , 545-548
Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum
- 1 September 2001
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (6) , 545-548
Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum